Margaret Foti: Devoted to cancer research
Mark Tykocinski: Open doors lead a scientist to his calling
Shire Pharmaceuticals: A Study in Exponential Growth
Many Happy Returns: Cephalon celebrates its 20th year
Matthew Gantz, CEO of Acureon Pharmaceuticals, says his company's technology is all "in our heads." That's because he and his partner are searching for late-stage therapeutics in the areas of infections, transplants, and critical care to improve for use in hospitals.
"We do not actually have a product; we are looking for one," says Gantz. "We look everywhere - databases, products approved outside the US but not here, serious unmet needs.... The challenge for us is to find the right product to build a business around."
Acureon was formed in the summer of 2006 in Berwyn, Pa., when Gantz's partner, Giorgio Mosconi, approached him with a product opportunity. Gantz, ...
